’ equity Issued and paid-up 400.00 400.00 - 0.00% Premium on paid-up capital 305.53 305.53 - 0.00% Share surplus from business combination under common control 20.64 20.64 - 0.00% Retained earnings 78.02

that will support continuous growth momentum in demand for medical devices in Thailand. In 2019, the Company has improved and increased the sales team to increase sales efficiency in distributor of

of risk from carrying successive losses of overall performance of Power Plant business caused by less productive machinery along with cutting down provision of financial support for Power Plant

sugar supply surplus in 2018 which still affects current price, now trade around 12 - 13 cent/lb. As a result, the Company recorded a decrease in average sugar price from the previous year but the Company

sugar supply surplus in 2018 which still affects current price, now trade around 12 - 13 cent/lb. As a result, the Company recorded a decrease in average sugar price from the previous year. Therefore the

surplus in 2018 with the additional of domestic price decrease from the new sugar regime that domestic price will float along with global price. As a result, the Company recorded average sugar price

to 12,526 THB/ton. At the beginning of 2017, world sugar price has climbed up to 20 cent/lb then dropped sharply to 12 – 13 cent/lb now, due to global sugar supply is surplus in 2018 with the

previous year (2018 net profit was THB 272 million). The decrease was due to the following reasons: 1. Revenue from sugar was decrease due to Global supply surplus in 2019 with addition of domestic price

decrease was due to the following reasons: 1 Due to Global supply surplus in 2018 with addition of domestic price decrease from new sugar regime that domestic price will float. As a result, gross profit

a rebound in December. Consequently, the current account surplus came in at USD 37.7 billion in 2018, narrowing from USD 50.2 billion in 2017. Global financial markets continued to experience